Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-12-13 3:50 pm Purchase |
2023-11-24 | 13G | Spyre Therapeutics, Inc. SYRE |
PERCEPTIVE ADVISORS LLC | 2,606,679 7.200% |
2,606,679 (New Position) |
Filing History |
| 2023-12-06 4:15 pm Purchase |
2023-12-04 | 13G | Applied Therapeutics, Inc. APLT |
PERCEPTIVE ADVISORS LLC | 4,580,249 5.900% |
4,580,249 (New Position) |
Filing History |
| 2023-11-27 4:16 pm Purchase |
2023-11-15 | 13G | Evolus, Inc. EOLS |
PERCEPTIVE ADVISORS LLC | 3,086,604 5.400% |
3,086,604 (New Position) |
Filing History |
| 2023-11-17 6:59 pm Purchase |
2023-11-17 | 13D | VBI VACCINES INC CDA COM VBIVQ |
PERCEPTIVE ADVISORS LLC | 1,381,355 5.800% |
1,381,355 (New Position) |
Filing History |
| 2023-11-16 9:18 pm Purchase |
2023-11-15 | 13D | Nautilus Biotechnology, Inc. NAUT |
PERCEPTIVE ADVISORS LLC | 12,594,211 10.100% |
3,683,060 (+41.33%) |
Filing History |
| 2023-11-14 4:15 pm Purchase |
2023-11-14 | 13G | CARGO Therapeutics, Inc. Common Stock CRGX |
PERCEPTIVE ADVISORS LLC | 3,246,168 8.400% |
3,246,168 (New Position) |
Filing History |
| 2023-10-23 4:20 pm Unchanged |
2023-10-20 | 13D | Soleno Therapeutics, Inc. SLNO |
PERCEPTIVE ADVISORS LLC | 3,074,542 10.100% |
0 (Unchanged) |
Filing History |
| 2023-10-18 6:07 pm Sale |
2023-10-16 | 13G | Aldeyra Therapeutics, Inc. ALDX |
PERCEPTIVE ADVISORS LLC | 8,593,586 14.700% |
-2,756,499 (-24.29%) |
Filing History |
| 2023-10-18 4:11 pm Purchase |
2023-10-16 | 13D | Astria Therapeutics, Inc. ATXS |
PERCEPTIVE ADVISORS LLC | 3,627,693 9.900% |
1,139,891 (+45.82%) |
Filing History |
| 2023-10-17 6:40 pm Unchanged |
2023-10-02 | 13D | ATHENEX INC ATNXQ |
PERCEPTIVE ADVISORS LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-10-17 4:35 pm Purchase |
2023-10-16 | 13D | Cerevel Therapeutics Holdings, Inc. CERE |
PERCEPTIVE ADVISORS LLC | 10,965,193 6.200% |
876,808 (+8.69%) |
Filing History |
| 2023-09-28 9:51 pm Purchase |
2023-09-26 | 13D | Soleno Therapeutics, Inc. SLNO |
PERCEPTIVE ADVISORS LLC | 3,074,542 23.700% |
866,789 (+39.26%) |
Filing History |
| 2023-09-13 4:16 pm Purchase |
2023-01-27 | 13G | Orchestra BioMed Holdings, Inc. OBIO |
PERCEPTIVE ADVISORS LLC | 2,432,089 6.800% |
2,432,089 (New Position) |
Filing History |
| 2023-09-08 12:47 pm Purchase |
2023-07-31 | 13G | Forte Biosciences, Inc. FBRX |
PERCEPTIVE ADVISORS LLC | 145,111 9.900% |
117,111 (+418.25%) |
Filing History |
| 2023-08-15 4:15 pm Unchanged |
2023-08-15 | 13D | Soleno Therapeutics, Inc. SLNO |
PERCEPTIVE ADVISORS LLC | 2,207,753 22.100% |
0 (Unchanged) |
Filing History |
| 2023-06-06 4:17 pm Purchase |
2023-06-02 | 13D | Soleno Therapeutics, Inc. SLNO |
PERCEPTIVE ADVISORS LLC | 2,207,753 27.000% |
178,298 (+8.79%) |
Filing History |
| 2023-06-02 4:16 pm Purchase |
2023-05-31 | 13D | Lyra Therapeutics, Inc. LYRA |
PERCEPTIVE ADVISORS LLC | 12,757,563 25.800% |
3,610,832 (+39.48%) |
Filing History |
| 2023-05-30 4:15 pm Purchase |
2023-05-26 | 13D | Soleno Therapeutics, Inc. SLNO |
PERCEPTIVE ADVISORS LLC | 2,029,455 24.800% |
85,000 (+4.37%) |
Filing History |
| 2023-05-25 4:58 pm Purchase |
2023-05-23 | 13D | Soleno Therapeutics, Inc. SLNO |
PERCEPTIVE ADVISORS LLC | 1,944,455 23.800% |
80,000 (+4.29%) |
Filing History |
| 2023-05-18 4:32 pm Purchase |
2023-05-11 | 13D | Soleno Therapeutics, Inc. SLNO |
PERCEPTIVE ADVISORS LLC | 1,864,455 22.800% |
1,864,455 (New Position) |
Filing History |